Skip to main content
Search
Main content
Acta neuropathologica
Published

Neuroimmune transcriptional signatures across repeat expansion ataxias in the human brain

Authors

Zhongbo Chen, Amy R Hicks, Jonathan Brenton, Melissa Grant-Peters, Regina H Reynolds, Clarissa Rocca, Guillermo Rocamora-Perez, Raquel Garza, Sonia Garcia-Ruiz, Natalia Dominik, Claire Anderson, Toby Curless, Kylie Montgomery, Hannah Macpherson, Suran Nethisinghe, Daria Gavriouchkina, Modesta Blunskyte-Hendley, Hanya Benotmane, Hermione Ugolini, Laura Caton, Eleanor Self, Aine Fairbrother-Browne, Jasmaine Lee, Huihui Luo, Stephanie Efthymiou, David Murphy, Andrea Cortese, Juan Botia, Nicholas Wood, John Hardy, Johan Jakobsson, Sonia Gandhi, Paola Giunti, Arianna Tucci, Emil K Gustavsson, Catriona McLean, Zane Jaunmuktane, Henry Houlden, Mina Ryten

Abstract

Acta Neuropathol. 2026 Nov 17;152(1):70. doi: 10.1007/s00401-026-03115-1.

ABSTRACT

Hereditary ataxias are neurodegenerative disorders characterised by progressive cerebellar dysfunction, most commonly caused by pathogenic repeat expansions of short tandem DNA repeats. Despite shared genetic mechanisms, the downstream molecular processes leading to neurodegeneration remain incompletely understood. RNA dysregulation has been proposed as a key contributor, but transcriptome-wide changes in human brain tissue across multiple ataxia subtypes have been poorly characterised. This study aims to identify shared and disease-specific transcriptional signatures across repeat expansion ataxias. We used bulk and single nucleus RNA-sequencing (snRNAseq) to analyse post-mortem brain tissue from individuals with repeat expansion ataxias in order to gain further mechanistic insight into disease biology. We analysed paired cerebellar and frontal cortex RNA-sequencing data from post-mortem brain tissue obtained from 23 donors with ataxia and 22 age- and sex-matched controls across two brain banks (including spinocerebellar ataxia (SCA)1, SCA2, SCA6, Friedreich's ataxia (FRDA), and cases with unknown molecular diagnoses). Bulk and snRNAseq analyses were used to examine transcript usage, differential gene expression, and cell-type-specific transcriptional changes and biological pathways across disease groups. These analyses revealed extensive transcriptional alterations in ataxia cases, affecting not only the cerebellum but also the frontal cortex. Across genetic subtypes, immune and inflammatory pathways were consistently activated and were associated with transcriptional changes in non-neuronal cell populations, alongside downregulation of neuronal and synaptic processes in the cerebellum. These findings were supported by snRNAseq, which demonstrated that immune-related transcriptional changes were most prominent in non-neuronal cell populations, including microglia and astrocytes. This process was accompanied by neuronal loss and relative expansion of glial populations in the cerebellum. Shared transcriptional signatures were evident across both molecularly diagnosed and undiagnosed cases. Hereditary ataxias are associated with common activation of immune and inflammatory pathways across brain regions and genetic subtypes, with prominent involvement of non-neuronal cell types. These findings highlight immune signalling as a shared feature of disease biology and suggest that inflammatory pathways may represent potential targets for therapeutic intervention. This study provides a comprehensive transcriptomic framework for understanding mechanisms underlying repeat expansion ataxias in the human brain.

PMID:43043476 | DOI:10.1007/s00401-026-03115-1

UK DRI Authors

Prof Sir John Hardy

Group Leader

Harnessing genetics to build a better understanding of dementia

Prof Sir John Hardy

Prof Sonia Gandhi

UK DRI Affiliate Member

Senior Group Leader and Assistant Research Director, The Francis Crick Institute

Prof Sonia Gandhi

Prof Henry Houlden

Group Leader

Investigating Parkinson’s and degenerative movement disorders across the full spectrum of patient populations

Prof Henry Houlden

Prof Mina Ryten

Centre Director & Research Division Lead

Leveraging brain transcriptomics to understand the pathophysiology of Lewy body disease

Prof Mina Ryten